| Literature DB >> 30945788 |
Stefan Petrasch1, Steven J Knapp1, Jan A L van Kan2, Barbara Blanco-Ulate1.
Abstract
The fungal pathogen Botrytis cinerea causes grey mould, a commercially damaging disease of strawberry. This pathogen affects fruit in the field, storage, transport and market. The presence of grey mould is the most common reason for fruit rejection by growers, shippers and consumers, leading to significant economic losses. Here, we review the biology and epidemiology of the pathogen, mechanisms of infection and the genetics of host plant resistance. The development of grey mould is affected by environmental and genetic factors; however, little is known about how B. cinerea and strawberry interact at the molecular level. Despite intensive efforts, breeding strawberry for resistance to grey mould has not been successful, and the mechanisms underlying tolerance to B. cinerea are poorly understood and under-investigated. Current control strategies against grey mould include pre- and postharvest fungicides, yet they are generally ineffective and expensive. In this review, we examine available research on horticultural management, chemical and biological control of the pathogen in the field and postharvest storage, and discuss their relevance for integrative disease management. Additionally, we identify and propose approaches for increasing resistance to B. cinerea in strawberry by tapping into natural genetic variation and manipulating host factors via genetic engineering and genome editing.Entities:
Keywords: disease management; fruit ripening; fruit-pathogen interaction; plant breeding; plant defence; primary infection; secondary infection
Year: 2019 PMID: 30945788 PMCID: PMC6637890 DOI: 10.1111/mpp.12794
Source DB: PubMed Journal: Mol Plant Pathol ISSN: 1364-3703 Impact factor: 5.663
Figure 1Symptoms of Botrytis cinerea infections in strawberry. Panel A shows a senesced flower with B. cinerea mycelium growth. Panel B shows an advanced floral infection. Panels C and D show infections of fruit at different stages. An infected petal can be seen as the source of fruit infection in Panel D. Browning of leaves due to B. cinerea infections is shown in Panels E and F.
Figure 2Botrytis cinerea disease cycle in strawberry. Sources of B. cinerea inoculum include infected leaves and sclerotia. Primary infections of flowers and secondary infections of fruit are depicted.
Figure 3Progression of Botrytis cinerea infection in ripe strawberries. Inoculation was performed by wounding the fruit and adding a B. cinerea conidia suspension on the surface of the wound. Fruit are shown immediately after inoculation, and at 24 h to 96 h post‐inoculation (hpi). Wounded controls are included.
Figure 4Ripening processes influence Botrytis cinerea infections of strawberries. Unripe fruit present unsuitable conditions for B. cinerea infection, while ripe fruit provide a favourable environment for pathogen growth. Pathogenicity factors are activated by B. cinerea during strawberry ripening and lead to increased susceptibility. ABA, abscisic acid; JA, jasmonic acid; PGIPs, PG‐inhibiting proteins; ROS, reactive oxygen species.
Registered fungicides for control of Botrytis cinerea in strawberry production.
| FRAC code | FRAC group | Target site | Target action | Risk of resistance | Example |
|---|---|---|---|---|---|
| FRAC 1 | Benzimidazoles | β‐tubulin assembly in mitosis | Cytoskeleton | High | Benomyl |
| FRAC 2 | Dicarboximides | MAP/histidine kinase in osmotic signal transduction (os‐1, Daf1) | Signal transduction | Medium to high | Iprodione |
| FRAC 7 | Succinate dehydro‐genase inhibitors | Succinate dehydrogenase | Respiration | Medium to high | Boscalid |
| FRAC 9 | Anilinopyrimidines | Methionine synthesis | Amino acid and protein synthesis | Medium | Cyprodinil |
| FRAC 11 | Quinone outside inhibitors | Cytochrome BC1 at Qo Site | Respiration | High | Azoxystrobin |
| FRAC 12 | Phenylpyrroles | MAP/histidine kinase in osmotic signal transduction (os‐2, HOG1) | Signal transduction | Low to medium | Fludioxonil |
| FRAC 17 | Sterol biosynthesis inhibitors class III | 3‐Keto reductase in C4 de‐methylation | Inhibition of sterol biosynthesis in membrane | Low to medium | Fenhexamid |
| FRAC M03 | Dithiocarbamates and relatives | Multi‐site mode of action | Low | Thiram | |
| FRAC M04 | Phthalimides | Multi‐Site Mode of Action | Low | Captan | |